METTL3 and esophageal squamous cell carcinoma: To explore the biological effects of METTL3 on ESCC cells, we utilized CRISPR/Cas9 technology to generate METTL3-knockout ESCC cell lines, Eca-109 and CaEs-17 (Table S1 and Fig. S2A, B).